Larvol Delta - Inhibikase-Therapeutics-Announces-Publication-Highlighting-Mechanism-of-Disease-and-the-Potential-of-Oral-cAbl-Kinase-Inhibitor-Therapy-for-the-Treatment-of-Parkinson39s-Disease

IkT-148009 - Inhibikase, Clintrex

https://www.prnewswire.com/news-releases/inhibikase-therapeutics-announces-publication-highlighting-mechanism-of-disease-and-the-potential-of-oral-c-abl-kinase-inhibitor-therapy-for-the-treatment-of-parkinsons-disease-301431718.html

Nov 29, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next